Phillip Monk
Directeur Technique/Scientifique/R&D chez SYNAIRGEN PLC
Fortune : 37 298 $ au 31/05/2024
Postes actifs de Phillip Monk
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SYNAIRGEN PLC | Directeur/Membre du Conseil | 03/09/2009 | - |
| Directeur Technique/Scientifique/R&D | 03/09/2009 | - | |
| Corporate Officer/Principal | 01/10/2006 | 03/09/2009 | |
Synairgen Research Ltd.
 Synairgen Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Synairgen Plc, Synairgen Research Ltd. is a British company that engages in respiratory biology and develops novel therapies. The company is based in Southampton, UK. Synairgen Research was founded in 2003. | Directeur/Membre du Conseil | 03/09/2009 | - |
Historique de carrière de Phillip Monk
Anciens postes connus de Phillip Monk
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - | - |
Statistiques
Internationale
| Royaume-Uni | 4 |
Opérationnelle
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SYNAIRGEN PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Synairgen Research Ltd.
Synairgen Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Synairgen Plc, Synairgen Research Ltd. is a British company that engages in respiratory biology and develops novel therapies. The company is based in Southampton, UK. Synairgen Research was founded in 2003. | Commercial Services |
- Bourse
- Insiders
- Phillip Monk
- Expérience
